Bionic devices market seen reaching $8.76 billion by 2030

The Business Research Company says the global bionic devices market is on track to grow from $6.37 billion in 2026 to $8.76 billion by 2030, driven by demand for more lifelike prosthetics, neural interface research and joint replacement procedures. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Bionic devices are moving from niche medical tools toward broader use in prosthetics, rehabilitation and joint replacement care. - The market growth points to rising demand for devices that improve mobility, reduce pain and restore function for people with disabilities and patients recovering from surgery.

What happened: - The Business Research Company released its Bionic Devices Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 on July 28, 2026. - The report pegs the bionic devices market at $6.37 billion in 2026, up from $5.88 billion in 2025. - The report forecasts the market will reach $8.76 billion by 2030, implying an 8.3% CAGR during the forecast period. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The company provides a free sample of the report and a full version of the market report.

The details: - Bionic devices combine mechanical and electronic components to imitate the function of limbs or organs. - Many bionic devices use sensors, actuators and sometimes neural interfaces to improve control and reproduce biological movement or processes. - The report cites rising limb loss from accidents and trauma, early adoption of electronic and myoelectric prosthetics, stronger rehabilitation and assistive programs, and advances in actuator and sensor technology as historical growth drivers. - The report says future growth will be driven by demand for highly responsive, lifelike prosthetics. - The report also points to more funding for neural interface and brain-machine interface research. - Broader use in rehabilitation medicine, better quality-of-life and mobility outcomes, and growth in customized patient-specific devices are also listed as growth factors. - One major demand driver is the increase in joint replacement procedures. - Joint replacements are being supported by an aging population, more osteoarthritis cases and advances in surgical methods and implant materials. - Bionic devices used in joint replacements are positioned to improve mobility, reduce pain and provide durable customized solutions. - In November 2024, the American Academy of Orthopaedic Surgeons reported that ambulatory surgery centers completed 62,110 total joint arthroplasty cases in 2023, a 70% increase from 2022. - The report says its 2026 market package includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics, key technology analysis and updated graphics and tables.

Between the lines: - The report frames bionic devices as part of a broader shift toward more personalized and function-restoring medical technology. - The jump in joint arthroplasty volume suggests demand is not limited to futuristic prosthetics and may also be tied to mainstream orthopedic procedures. - Asia-Pacific’s faster expected growth likely reflects expanding healthcare access and adoption, while North America’s lead suggests the region remains the most mature market.

What's next: - The market is expected to keep expanding through 2030 as neural-interface research, prosthetics innovation and rehabilitation use cases scale. - Patient-specific device development is likely to become a bigger focus as manufacturers pursue more lifelike movement and better functional outcomes. - The report indicates ongoing regional competition between a mature North American market and faster-growing Asia-Pacific demand.

The bottom line: - The bionic devices market is entering a steady growth phase, with the strongest near-term demand coming from prosthetics, rehabilitation and joint replacement applications.